Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolcapone for Self-Regulation in Mild TBI
NCT02260570Phase 1Completed
- Sponsor
- VA Office of Research & Development
- Start
- Aug 2015
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tolcapone in traumatic brain injury (TBI) (2 arms), sponsored by VA Office of Research & Development. Primary endpoints: Blood Oxygen Level Dependent Brain Signal and Performance on Cognitive Testing. Started Aug 2015; status: completed.
02
Drugs
tolcapone
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02260570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260570.